Search results for “Angiopoietins” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 234 patents, we discovered top 48 key players by total patent application. Novartis AG, Ionis Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 30.77% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 36
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 20
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 16
Amgen, Inc.
California, United States
Patent: 14
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 13
Mesoblast International SARL
Switzerland
Patent: 10
Eli Lilly & Co.
Indiana, United States
Patent: 9
STARTUP
Empirico, Inc.
California, United States
Patent: 8
Pacific Arrow
Japan
Patent: 8
EyeGene, Inc.
South Korea
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 4 start-ups by total patent application. Empirico, Inc., Quthero, Inc., Drive Therapeutics, L L C are active in this area.
STARTUP
Empirico, Inc.
California, United States
Patent: 8
STARTUP
Quthero, Inc.
United States
Patent: 1
STARTUP
Drive Therapeutics, L L C
North Carolina, United States
Patent: 1
Aprogen, Inc. /Old/
Gyeonggi-do, South Korea
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 111 patents applied in the last 5 years. We discover 33 most active companies in this area. The fast-growing Novartis AG, Empirico, Inc., Ionis Pharmaceuticals, Inc. take 38.74% of patent filing during this period.
Novartis AG
Basel-Stadt, Switzerland
Patent: 27
STARTUP
Empirico, Inc.
California, United States
Patent: 8
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 8
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 7
PharmAbcine Inc.
South Korea
Patent: 7
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 6
Mesoblast International SARL
Switzerland
Patent: 4
Rapid Pathogen Screening, Inc.
United States
Patent: 4
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 4
uniQure IP BV
Netherlands
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 111 patents in last 5 years, we discover 24 new entrants. Empirico, Inc., PharmAbcine Inc., Arrowhead Pharmaceuticals, Inc. are the most active new entrants in this area.
STARTUP
Empirico, Inc.
California, United States
Patent: 8
PharmAbcine Inc.
South Korea
Patent: 7
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 6
Rapid Pathogen Screening, Inc.
United States
Patent: 4
uniQure IP BV
Netherlands
Patent: 3
Sanyu Biotechnology Co., Ltd
undefined undefined
Patent: 3
Hospital Clínic de Barcelona
Spain
Patent: 2
NEORTESBIO Inc.
South Korea
Patent: 2
Dicerna Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
CellResearch Corp. Pte Ltd.
Central Region, Singapore
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 3 universities and scientific research institutions by total patent application.
University of Washington
Washington, United States
Patent: 1
University of Leicester
LEICESTER, United Kingdom
Patent: 1
Osaka University
Osaka-fu, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: